Clinical Trial Update: Intravitreal Ranibizumab For Persistent New Vessels In Diabetic Retinopathy(Inipe Study) [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update describing intravitreal ranibizumab for persistent new vessels in proliferative diabetic retinopathy, covering Phase 1 and Phase 2 studi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Proliferative Diabetic Retinopathy

Drugs mentioned

• Lucentis (ranibizumab)

Snippet

Sponsor: University of Sao Paulo | Conditions: Proliferative Diabetic Retinopathy | Phase 1, Phase 2 | Status: UNKNOWN